Disorders in the metabolism of glutathione and imidazole dipeptides

Inborn Metabolic Diseases: Diagnosis and Treatment

Volumn , Issue , 2006, Pages 373-380

  Ristoff, Ellinor ^a   Larsson, Agne ^a   Jaeken, Jaak ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951022818     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-28785-8_30     Document Type: Chapter

References (57)

1. Konrad PN, Richards FD, Valentine WN, Paglia DE (1972) γ-Glutamylcysteine synthetase deficiency. A cause of hereditary hemolytic anemia. N Engl J Med 286:557-561
2. Beutler E, Moroose R, Kramer L et al (1990) Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia. Blood 75:271-273
3. Hirono A, Iyori H, Sekine I et al (1996) Three cases of hereditary nonspherocytic hemolytic anemia associated with red blood cell glutathione deficiency. Blood 87:2071-2074
4. Beutler E, Gelbart T, Kondo T, Matsunaga A T (1999) The molecular basis of a case of γ-glutamylcysteine synthetase deficiency. Blood 94:2890-2894
5. Ristoff E, Augustson C, Geissler J et al (2000) A missense mutation in the heavy subunit of γ-glutamylcysteine synthetase gene causes hemolytic anemia. Blood 95:2193-2196
6. Prins H K, Oort M, Zurcher C, Beckers T (1966) Congenital nonspherocytic hemolytic anemia, associated with glutathione deficiency of the erythrocytes. Hematologic, biochemical and genetic studies. Blood 27:145-166
7. Sierra-Rivera E, Dasouki M, Summar M L et al (1996) Assignment of the human gene (GLCLR) that encodes the regulatory subunit of γ- glutamylcysteine synthetase to chromosome 1p21. Cytogenet Cell Genet 72:252-254
8. Sierra-Rivera E, Summar M L, Dasouki M et al (1995) Assignment of the gene (GLCLC) that encodes the heavy subunit of γ-glutamylcysteine synthetase to human chromosome 6. Cytogenet Cell Genet 70:278-279
9. Hamilton D, Wu J H, Alaoui-Jamali M, Batist G (2003) A novel missense mutation in the γ-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production. Blood 102:725-730
10. Ristoff E, Mayatepek E, Larsson A (2001) Long-term clinical outcome in patients with glutathione synthetase deficiency. J Pediatr 139:79-84
11. Skullerud K, Marstein S, Schrader H et al (1980) The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinuria). Acta Neuropathol 52:235-238
12. Ristoff E, Hebert C, Njalsson R et al (2002) Glutathione synthetase deficiency: is γ-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione? J Inherit Metab Dis 25:577-584
13. Webb GC, Vaska VL, Gali RR et al (1995) The gene encoding human glutathione synthetase (GSS) maps to the long arm of chromosome 20 at band 11.2. Genomics 30:617-619
14. Shi ZZ, Habib GM, Rhead WJ et al. (1996) Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet 14:361-365
15. Dahl N, Pigg M, Ristoff E et al (1997) Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet 6:1147-1152
16. Al-Jishi E, Meyer BF, Rashed MS et al (1999) Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency. Clin Genet 55:444-449
17. Njalsson R, Carlsson K, Winkler A et al (2003) Diagnostics in patients with glutathione synthetase deficiency but without mutations in the exons of the GSS gene. Hum Mutat 22:497
18. Erasmus E, Mienie LJ, de Vries WN et al (1993) Prenatal analysis in two suspected cases of glutathione synthetase deficiency. J Inherit Metab Dis 16:837-843
19. Manning NJ, Davies NP, Olpin SE et al (1994) Prenatal diagnosis of glutathione synthase deficiency. Prenat Diagn 14:475-478
20. Ristoff E, Augustson C, Larsson A (1999) Generalized glutathione synthetase deficiency and pregnancy. J Inherit Metab Dis 22:758-759
21. Janaky R, Varga V, Hermann A et al (2000) Mechanisms of L-cysteine neurotoxicity. Neurochem Res 25:1397-1405
22. Fonnum F, Lock EA (2000) Cerebellum as a target for toxic substances. Toxicol Lett 112-113:9-16
23. Goodman SI, Mace JW, Pollack S (1971) Serum γ-glutamyl transpeptidase deficiency. Lancet 1:234-235
24. O'Daley S (1968) An abnormal sulphydryl compound in urine. Irish J Med Sci 7:578-579
25. Wright EC, Stern J, Ersser R, Patrick AD (1980) Glutathionuria: γ-glutamyl transpeptidase deficiency. J Inherit Metab Dis 2:3-7
26. Hammond JW, Potter M, Wilcken B, Truscott R (1995) Siblings with γ-glutamyltransferase deficiency. J Inherit Metab Dis 18:82-83
27. Lieberman MW, Wiseman AL, Shi ZZ et al (1996) Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci U S A 93:7923-7926
28. Harding CO, Williams P, Wagner E et al (1997) Mice with genetic γ-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility. J Biol Chem 272:12560-12567
29. Bulle F, Mattei MG, Siegrist S et al (1987) Assignment of the human γ-glutamyl transferase gene to the long arm of chromosome 22. Hum Genet 76:283-286
30. Courtay C, Heisterkamp N, Siest G, Groffen J (1994) Expression of multiple γ-glutamyltransferase genes in man. Biochem J 297:503-508
31. Schulman JD, Goodman SI, Mace JW et al (1975) Glutathionuria: inborn error of metabolism due to tissue deficiency of γ-glutamyl transpeptidase. Biochem Biophys Res Commun 65:68-74
32. Henderson MJ, Larsson A, Carlsson B, Dear PR (1993) 5-Oxoprolinuria associated with 5-oxoprolinase deficiency; further evidence that this is a benign disorder. J Inherit Metab Dis 16:1051-1052
33. Roesel RA, Hommes FA, Samper L (1981) Pyroglutamic aciduria (5-oxoprolinuria) without glutathione synthetase deficiency and with decreased pyroglutamate hydrolase activity. J Inherit Metab Dis 4:89-90
34. Bernier FP, Snyder FF, McLeod DR (1996) Deficiency of 5-oxoprolinase in an 8-year-old with developmental delay. J Inherit Metab Dis 19:367-368
35. Cohen LH, Vamos E, Heinrichs C et al (1997) Growth failure, encephalopathy, and endocrine dysfunctions in two siblings, one with 5-oxoprolinase deficiency. Eur J Pediatr 156:935-938
36. Mayatepek E, Hoffmann GF, Larsson A et al (1995) 5-Oxoprolinase deficiency associated with severe psychomotor developmental delay, failure to thrive, microcephaly and microcytic anaemia. J Inherit Metab Dis 18:83-84
37. Ye GJ, Breslow EB, Meister A (1996) The amino acid sequence of rat kidney 5-oxo-L-prolinase determined by cDNA cloning. J Biol Chem 271:32293-32300
38. Tham R, Nystrom L, Holmstedt B (1968) Identification by mass spectrometry of pyroglutamic acid as a peak in the gas chromatography of human urine. Biochem Pharmacol 17:1735-1738
39. Oberholzer VG, Wood CB, Palmer T, Harrison BM (1975) Increased pyroglutamic acid levels in patients on artificial diets. Clin Chim Acta 62:299-304
40. Stokke O, Marstein S, Jellum E, Lie SO (1982) Accumulation of pyroglutamic acid (5-oxoproline) in homocystinuria. Scand J Clin Lab Invest 42:361-369
41. Croal BL, Glen A C, Kelly CJ, Logan RW (1998) Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. Clin Chem 44:336-340
42. Jackson AA, Persaud C, Hall M et al (1997) Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants. Arch Dis Child Fetal Neonatal Ed 76:F152-157
43. Jackson AA, Badaloo AV, Forrester T et al (1987) Urinary excretion of 5-oxoproline (pyroglutamic aciduria) as an index of glycine insufficiency in normal man. Br J Nutr 58:207-214
44. Perry TL, Hansen S, Tischler B et al (1967) Carnosinemia: a new metabolic disorder associated with neurological disease and mental defect. N Engl J Med 277:1219-1227
45. Gjessing LR, Lunde HA, Morkrid L, Lenner JF, Sjaastadt O (1990) Inborn errors or carnosine and homocarnosine metabolism. J Neural Transm 29 [Suppl]: 91-106
46. Cohen M, Hartlage PL, Krawiecki N et al (1985) Serum carnosinase deficiency: a non-disabling phenotype? J Ment Defic Res 29:383-389
47. Willi SM, Zhang Y, Hill JB et al (1997) A deletion in the long arm of chromosome 18 in a child with serum carnosinase deficiency. Pediatr Res 41:210-213
48. Wassif WS, Sherwood RA, Amir A et al (1994) Serum carnosinase activity in central nervous system disorders. Clin Chim Acta 225:57-64
49. Sjaastadt O, Berstadt J, Gjesdahl P, Gjessing L (1976) Homocarnosinosis. 2. A familial metabolic disorder associated with spastic paraplegia, progressive mental deficiency, and retinal pigmentation. Acta Neurol Scand 53:275-290
50. Kramarenko GG, Markova ED, Ivanova-Smolenskaya IA, Boldyrev AA (2001) Peculiarities of carnosine metabolism in a patient with pronounced hypercarnosinemia. Bull Exp Biol Med 132:996-999
51. Lenney JF, Peppers SC, Kucera CM, Sjaastadt O (1983) Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine. Clin Chim Acta 132:157-165
52. Goodman SI, Solomons CC, Muschenheim F et al (1968) A syndrome resembling lathyrism associated with iminodipeptiduria. Am J Med 45:152-159
53. Shrinath M, Walter JH, Haeney M et al (1997) Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child 76:441-444
54. Ledoux P, Scriver CR, Hechtman P (1996) Expression and molecular analysis of mutations in prolidase deficiency. Am J Hum Genet 59:1035-1039
55. Lupi A, De Riso A, Della Torre S et al (2004) Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: naturally occurring mutations as a tool to investigate structurefunction relationship. J Hum Genet 49:500-506
56. Jemec GB, Moe AT (1996) Topical treatment of skin ulcers in prolidase deficiency. Pediatr Dermatol 13:58-60
57. Perugini P, Hassan K, Genta I et al (2005) Intracellular delivery of liposomeencapsulated prolidase in cultured fibroblasts from prolidasedeficient patients. J Controlled Release 102:181-190